Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

D.D. Mikol, F. Barkhof, P. Chang, P.K. Coyle, D.R. Jeffery, S.R. Schwid, B. Stubinski, B.M.J. Uitdehaag

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)903-914
JournalLancet Neurology
Volume7
Issue number10
DOIs
Publication statusPublished - 2008

Cite this